Insulin production or insulin resistance or inefficient B-cells

Answer by Dr. Albana Greca, MD, MMedSc

Hello Varun,

Diabetes is not one disorder. Insulin resistance and beta-cell failure often occur together. Testing aims to classify diabetes well enough to choose safe treatment, not always to identify one isolated defect.

Tests That Confirm Diabetes

Fasting glucose, HbA1c, a two-hour oral glucose tolerance test and random glucose with classic symptoms can diagnose diabetes. They do not reliably distinguish type 1, type 2, pancreatic or monogenic diabetes. See our diabetes blood-test guide.

Step 1: Review the Clinical Pattern

The clinician considers age at onset, speed of symptoms, weight loss, ketones, body size, family history, pregnancy, medicines, pancreatic disease and response to treatment.

• Autoimmune diabetes is more likely with rapid onset, weight loss, ketosis, other autoimmune disease or an early need for insulin.


• Type 2 diabetes is more likely with gradual onset, overweight, central obesity, high blood pressure, abnormal triglycerides, fatty liver or a strong family history.


• Pancreatic diabetes is considered after chronic pancreatitis, pancreatic surgery, pancreatic cancer, cystic fibrosis or signs of poor digestion.


• Monogenic diabetes is considered with young-onset diabetes, a strong pattern across generations, negative antibodies and preserved insulin production.

These features overlap, so age or body weight alone cannot establish the type. See our overview of the main types and causes of diabetes mellitus.

Step 2: Islet Autoantibody Tests

If autoimmune diabetes is possible, the doctor may order GAD, IA-2 and ZnT8 antibodies. Insulin autoantibodies are most useful before or soon after insulin treatment begins because injected insulin can affect interpretation.

Positive antibodies support autoimmune diabetes. Negative results do not completely exclude it, especially after many years. See our type 1 diabetes guide.

Step 3: C-Peptide to Estimate Insulin Production

C-peptide is released in equal amounts when the pancreas makes its own insulin. Injected insulin does not contain C-peptide, so the test can estimate remaining natural insulin production in a person using insulin.

Interpret C-peptide with a glucose result taken at the same time. Very low C-peptide during adequate or high glucose suggests severe insulin deficiency. A preserved result shows continuing insulin production but does not prove insulin resistance or type 2 diabetes.

C-peptide may mislead when glucose is low, kidney function is reduced, the person is fasting, or testing follows a hyperglycemic emergency. Never use it alone to stop insulin. It may remain measurable early in type 1 diabetes and become low in long-standing type 2 diabetes.

How Is Insulin Resistance Identified?

Insulin resistance is usually assessed from the overall pattern. Clues include central weight gain, acanthosis nigricans, high triglycerides, low HDL, fatty liver, polycystic ovary syndrome, hypertension and family history.

Normal or high C-peptide during hyperglycemia supports preserved insulin production but does not precisely measure resistance. See what insulin resistance means.

When Are Other Tests Needed?

Order additional tests only when the history or examination suggests a specific cause:

• Pancreatic disease: pancreatic imaging, stool elastase or other digestive tests when there is pancreatitis, surgery, abdominal pain, oily stools or unexplained weight loss.


• Monogenic diabetes: genetic counseling and testing when age, family pattern, antibody results and C-peptide make MODY or neonatal diabetes plausible.


• Hormonal disease: cortisol, growth-hormone or other testing only when physical signs suggest Cushing syndrome, acromegaly or another endocrine disorder.


• Medication-related diabetes: review of glucocorticoids, some antipsychotics, transplant medicines and other drugs that can raise glucose.


• Liver and kidney health: routine chemistry tests help guide treatment and identify associated disease, but fatty liver usually reflects insulin resistance rather than proving the diabetes type.

Allergy, heavy-metal and toxin tests are not routine unless a specific exposure or separate clinical reason exists.

Questions for Your Clinician

• Does my history look more like type 1, type 2 or a secondary form?


• Should I have GAD, IA-2 and ZnT8 antibody tests?


• Would C-peptide with simultaneous glucose change my treatment?


• Is there evidence of pancreatic disease or a medicine-related cause?


• Do my age and family history justify monogenic-diabetes genetic testing?

No test proves every case. Treatment must still address glucose, insulin deficiency, cardiovascular and kidney risk, and response to therapy.

Related Resources

• Symptoms and signs of insulin resistance


• Diabetes blood tests and diagnostic thresholds


• How to improve diabetes control safely

This educational answer does not replace classification and test interpretation by a clinician.